RMC
Resimac Group Ltd
🇦🇺 ASX
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💰
8.08%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Resimac Group Ltd. engages in the provision of mortgage origination and management of home loans. The company is headquartered in Sydney, New South Wales. The company went IPO on 2001-03-19. The firm is focused on distributing prime and specialist products across multiple channels. The company operates primarily in Australia and New Zealand, originating a quality loan portfolio, loan servicing capability, and global funding program. The company offers a suite of lending products to consumers and commercial borrowers across its wholly owned subsidiaries. These products include residential home loans, consumer finance, and small and medium enterprises (SME) finance. The company also offers home loans directly to consumers via its homeloans.com.au brand, with a range of smart and transparent home loan solutions that borrowers can apply for using its end-to-end online application. The company offers a range of financial solutions for SMEs and commercial borrowers through its Resimac Asset Finance brand. Its subsidiaries include Resimac Asset Finance Pty Limited and RESIMAC NZ Home Loans Ltd.
📈 Performance
Price History
+56.90%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
8.08%
💰 Annual Dividend Earnings Per $1,000 invested**
$80.81
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
100.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.08
100.00%
2021
$0.06
100.00%
2020
$0.03
100.00%
2019
$0.03
50.00%
2018
$0.02
100.00%
2017
$0.01
100.00%
2016
$0.04
100.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.91
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in RMC
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in RMC
1077 days
RMC investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in RMC also invest in...
Woodside Energy Group Ltd. engages in the exploration, evaluation, development, and production of hydrocarbon and oil and gas properties. The company is headquartered in Perth, Western Australia and currently employs 4,376 full-time employees. The firm's segments include Australia, International and Marketing. The Australia segment engaged in the exploration, evaluation, development, production and sale of liquified natural gas, pipeline gas, crude oil and condensate and natural gas liquids in Australia. The International segment engaged in the exploration, evaluation, development, production and sale of pipeline gas, crude oil & condensate and natural gas liquids in international jurisdictions outside of Australia. The Marketing segment engaged in trading of liquified natural gas (non-produced) and optimization activities generating incremental value from produced liquified natural gas via scheduling, shipping and/or contract management. The Company’s projects include Pluto LNG, Northwest Shelf project, Wheatstone and Julimar-Brunello, Macedon, Bass Strait, Calypso, Browse, Wildling, Atlantis, Woodside Solar project and Scarborough and Pluto Train 2.
📊 Share price
$35.22 AUD
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
📊 Share price
$100.01 AUD
NULL GLOBAL
NULL OTHER
NULL SMART BETA
NULL THEMATIC
NULL INDEX
ASIA.AX was created on 2018-09-18 by BetaShares. The fund's investment portfolio concentrates primarily on information technology equity. The investment objective of the BetaShares Asia Technology Tigers ETF is to provide an investment return that aims to track the performance of the Solactive Asia ex-Japan Technology & Internet Tigers Index (the Index), before taking into account fees and expenses.
📊 Share price
$7.28 AUD
NULL ASIA
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
📊 Share price
$29.97 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
Want more shares? Try these...
RMD
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 8,160 full-time employees. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The company also offers software solutions for a variety of out-of-hospital care providers. The firm has two segments: Sleep and Respiratory Care and the Software-as-a-Service. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The firm's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices and cloud-based software informatics solutions.
📊 Share price
